Lynn Verplank

Lynn VerPlank has extensive experience in the scientific field, ranging from academia to industry. They specialize in in vitro ADME-Tox assay services and have managed multiple roles in various companies, including Cyprotex, Icagen, Broad Institute, and Harvard Medical School. With a Ph.D. in Molecular Microbiology and a BS in Molecular Biology, Lynn has a strong background in research and laboratory work, making significant contributions to the field of biology.